Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (Details 3)

v3.20.2
STOCKHOLDERS EQUITY (Details 3) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Stock-based compensation $ 715,608 $ 726,736 $ 1,392,156 $ 1,363,999
Research and development [Member]        
Stock-based compensation 105,029 89,543 15,754 176,066
Plasma centers [Member]        
Stock-based compensation 8,510 13,213 15,754 24,753
Selling, general and administrative [Member]        
Stock-based compensation 539,256 569,349 1,063,145 1,067,820
Cost of product revenue [Member]        
Stock-based compensation $ 62,813 $ 54,631 $ 114,654 $ 95,360